Search News Archives
Social Media
Will BRIC be the Savior for the Life Sciences and Medical Devices Sector? Seal of Approval for Pepceuticals ZEISS Lightsheet Z.1 awarded with Best New Life Science Product of 2012 IDT and SGI-DNA Broaden Their Collaboration to Provide Synthetic DNA Products up to 2 Mbp Watson-Marlow OEM pumps help push the boundaries of automated cell culture Breakthrough in non-invasive gut health testing New Portable SPECTROSCOUT XRF Analyzer - the Lab that Goes Anywhere ZEISS SIGMA used to analyze Russian meteorite that fell in Chelyabinsk region
Waters Updates Alliance HPLC Designs Without Impacting Established Validated Methods Porvair Sciences Expands Product Range for Epigenetics Thermo Fisher Scientific Introduces Gas Chromatography Headspace Autosampler for Organic Volatiles New Amicon® Pro Purification System for Protein Purification from Merck Millipore Wyatt Calypso Succeeds in ABRF-MIRG Study Revolutionize your pipetting with the new Biohit Picus electronic pipette Easy, Reliable Weighing in Regulated Areas Phenom proX all-in-one desktop SEM Flash of inspiration in the shaft tunnel - IKA launches the new video for UTTD control The only Chromatography Autosampler you will ever need! JG Finneran Associates introduces the 96-Well Multi-Tier Microtiter Plate System (Patented) IC for the people – Metrohm celebrates 25 years of ion chromatography
For further information or to sign up to receive any of our E-Newsletters click here Reading and Imaging are Combined in BioTek's Revolutionary, New Cytation™3 ZEISS SIGMA used to analyze Russian meteorite that fell in Chelyabinsk region New SPOT Insight™ Gigabit Camera Brings Microscopy Presentations to Life ZEISS Lightsheet Z.1 awarded with Best New Life Science Product of 2012 Malvern’s Dr E Neil Lewis takes his place among chemical imaging pioneers Waters Biopharmaceutical, Bioanalysis and Screening Solutions Now Shipping with UNIFI 1.6 New Software for Research & Scientific Thermal Imagers Thermo Fisher Scientific Introduces Data System to Unite Chromatography and Mass Spectrometry Molecular Devices Introduces SoftMax Pro 6 GxP Microplate Data Acquisition and Analysis Software Short Guide to 3D Cell Culture New EFS Handbook Published by Lee Products The Perfect Ultrafiltration Device for Your Specific Need Electron Magnetic Resonance shrinks to fit the undergraduate curriculum Biotage Releases New Catalog and Technical Guide for Sample Preparation and Evaporation New Waters Quality Parts, Chromatography Columns and Supplies Catalog
|
Spinnovation Biologics Spedia-NMR™ Gains Momentum in Client Adoption
publication date: Dec 14, 2011
|
author/source: Spinnovation Analytical BV
 Increasing demand for Spedia-NMRTM technology from Spinnovation Biologics is expected to continue. This analytical service proves its value in providing fast, fine-tuning of cell culture feeding strategy, delivering improved cell viability and higher product yield. Unique to Spinnovation Biologics - the new division of Spinnovation
Analytical BV (Nijmegen, The Netherlands) - Spedia-NMRTM has shown
itself to be faster and more reproducible than liquid chromatography
(LC)-based methods for cell culture media analysis. Spinnovation
Biologics now provides NMR services to 20 major biotech companies, one
of which is in the world top 10 Biopharma. The number of companies
realising the benefits of Spedia-NMRTM is increasing every month, with 25
more biotechs currently evaluating the benefits of the service.Spedia-NMRTM
provides rapid, quantitative multiplex analysis of spent cell culture
media, quickly identifying which feed components are most influenced by
process change. Results include information on the production and
accumulation of metabolites and toxic components.Spedia-NMRTM is able to evaluate over 50 analytes at a time providing robust and cost efficient results with ideal linearity (R >= 0.99) over a large dynamic range (from 10 µM to 0.5 M) and limit of detection at approximately 1 µM. The service provides a detailed analysis including volatile metabolites and can even identify unanticipated unknowns, saving the time and cost of multiple analyses. "The increasing uptake of Spedia-NMRTM services by Biopharma and biotech clients reflects a high demand for high throughput, detailed analysis of bioprocesses", commented Dr. Frederic Girard, CEO of Spinnovation Analytical. "Our clients are using the Spedia-NMRTM data to optimize and standardize conditions in preparation for large-scale manufacturing of biologics, which they can do within a far shorter timeframe using our technology." Spinnovation Biologics offers Spedia-NMRTM alongside a wide range of complementary analysis methods including LC-MS, LC-NMR, LC-SPE-NMR, LC-SPE-NMR-MS, for troubleshooting in bioprocess and performing simple to complex profiling and characterization of biologics and biosimilars (including peptides, proteins, oligo/polysaccharides). All services are available on a contract or pay-per-sample basis to suit individual client requirements. Further information including case studies demonstrating the new Spedia-NMRTM technology, can be found at: www.spinnovation-biologics.com Spedia-NMRTM is a registered trademark of Spinnovation Analytical BV |
|
